Radford, J 2020, ' Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY) ', British Jounal Haematology . https://doi.org/10.1111/bjh.17073
Booth, S, Plaschkes, H, Kirkwood, A A, Gibb, A, Horgan, P, Higham, C, Oladipo, J M, Browning, J, Khan, U, Tseu, B, Chen, L, Willan, J, Wolf, J, Gunawan, A, Fields, P, Ebsworth, T, Lown, R, Gordon-Walker, D, Shah, N, Linton, K M, Collins, G P, Kothari, J, Hildyard, C & Eyre, T A 2020, ' Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma ', Blood Advances, vol. 4, no. 18, pp. 4337-4346 . https://doi.org/10.1182/BLOODADVANCES.2020002553 Blood Adv
Russell, B, Moss, C, Papa, S, Irshad, S, Ross, P, Spicer, J, Kordasti, S, Crawley, D, Wylie, H, Cahill, F, Haire, A, Zaki, K, Rahman, F, Sita-Lumsden, A, Josephs, D, Enting, D, Lei, M, Ghosh, S, Harrison, C, Swampillai, A, Sawyer, E, D'Souza, A, Gomberg, S, Fields, P, Wrench, D, Raj, K, Gleeson, M, Bailey, K, Dillon, R, Streetly, M, Rigg, A, Sullivan, R, Dolly, S & Van Hemelrijck, M 2020, ' Factors Affecting COVID-19 Outcomes in Cancer Patients : A First Report From Guy's Cancer Center in London ', Frontiers in oncology, vol. 26, no. 18, 1279 . https://doi.org/10.3389/fonc.2020.01279 Russell, B, Moss, C, Papa, S, Irshad, S, Ross, P, Spicer, J, Kordasti, S, Crawley, D, Wylie, H, Cahill, F, Haire, A, Zaki, K, Rahman, F, Sita-Lumsden, A, Josephs, D, Enting, D, Lei, M, Ghosh, S, Harrison, C, Swampillai, A, Sawyer, E, D'Souza, A, Gomberg, S, Fields, P, Wrench, D, Raj, K, Gleeson, M, Bailey, K, Dillon, R, Streetly, M, Rigg, A, Sullivan, R, Dolly, S & Van Hemelrijck, M 2020, ' Factors Affecting COVID-19 Outcomes in Cancer Patients : A First Report From Guy's Cancer Center in London ', Frontiers in oncology, vol. 10, 1279 . https://doi.org/10.3389/fonc.2020.01279 Frontiers in Oncology, Vol 10 (2020) Frontiers in Oncology